News

Codeine Phosphate Injection Market Analysis Spreads In 66 Pages with 108 Figures and Tables – Sector : Pharma & Healthcare

Umang January 13, 2023

2 minutes read

[66 Pages Report with Detailed Analysis] Codeine Phosphate Injection Market (Description) : Codeine phosphate injection, used for analgesia, mainly moderate or above pain can be used for sedation, in addition, cough suppressant, used for severe dry cough, because of its addictive nature, belongs to the special controlled drugs.

Highlights

The global Codeine Phosphate Injection market is projected to reach USD million by 2028 from an estimated USD million in 2022, at a CAGR of % during 2023 and 2028.

North American market for Codeine Phosphate Injection is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for Codeine Phosphate Injection is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The major global manufacturers of Codeine Phosphate Injection include Nepharm and Humanwell Pharma etc. In 2021, the world’s top three vendors accounted for approximately % of the revenue.

The global market for Codeine Phosphate Injection in Narcotic Analgesic is estimated to increase from USD million in 2022 to USD million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, 15mg, which accounted for % of the global market of Codeine Phosphate Injection in 2021, is expected to reach million USD by 2028, growing at a revised CAGR of % from 2022 to 2028.

SEGMENTATION ANALYSIS

Top Key players:

Nepharm

Humanwell Pharma

By Types

15mg

30mg

By Application

Narcotic Analgesic

Antitussive

Others

Get a Sample PDF of report – https://www.360researchreports.com/enquiry/request-sample/21992200